DARA $.58 - Down 10% after financials and no mention of ODD update. They re-submitted ODD paperwork in November and typically an answer is given in 90 days from what I've read. Although the original submission was a year or so ago. So a verrrryyyyy long delay so far.
-------------------
Provided U.S. Food and Drug Administration (FDA), on November 19, 2013, with additional information requested in support of DARA's request for orphan drug designation for the Company's Phase 2 development asset, KRN5500, for the treatment of painful, treatment-refractory, chronic chemotherapy-induced peripheral neuropathy ("CCIPN").
-------------------
Will be meeting on reverse stock split on Feb 5 and the investor conference/presentation is on Monday.
I am holding for a little while more. Will see what happens in meeting tomorrow and into next week. Am in no hurry to sell, so will wait it out for now.
These thoughts are just mine, not right, not wrong, just thoughts. Invest in what you believe in, not what I believe in. Do your research, and invest in the facts.
